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Ten synthetic analogs of the marine alkaloids tambjamines, bearing aromatic enamine moieties, have 
been synthesized. These compounds proved to be highly efficient transmembrane anion transporters in 
model liposomes. Changes in the electronic nature of the substituents of the aromatic enamine or the 
alkoxy group of the central pyrrole group did not affect this anionophore activity. The in vitro activity of 10 
these compounds has also been studied. They triggered apoptosis in several cancer cell lines with IC50 
values in the low micromolar range as well as modify the intracellular pH inducing the basification of 
acidic organelles. 
Introduction 
The development of small molecules capable of facilitating the 15 
transmembrane transport of ions is an active field of research.1 
These compounds can mimic the activity of natural ionophores, 
which are widely used as antibiotics and tools for biomembrane 
research.2 Their potential as future anticancer drugs and 
chemotherapeutics in conditions related to the dysfunction of 20 
natural transport mechanisms is starting to be recognized.3 The 
majority of these compounds facilitate the transmembrane 
transport of cations and anion selective ionophores are relatively 
scarce, the prodiginines being the most representative examples.4 
These compounds display intriguing pharmacological activities, 25 
and there is a growing evidence linking the ionophoric activity of 
these molecules and their cytotoxicity.5 These molecules can 
permeabilize cellular membranes, upsetting the normal ionic 
balance and modifying the intracellular pH, triggering apoptosis. 
 We decided to study the marine alkaloids tambjamines. These 30 
naturally occurring compounds are structurally related to the 
prodiginines, being characterized by an imine substituted 4-
methoxy-1H,1'H-2,2'-bipyrrole moiety.6 Likewise, these 
compounds have been shown to display antimicrobial and 
antitumor activities.7 The mechanism of action of these 35 
compounds is unclear but may involve their ionophoric activity.5 
We recently reported the anion transport activities of some 
tambjamine derivatives.8 They proved to be very efficient anion 
exchangers in model liposomes, promoting both chloride and 
bicarbonate transport. All naturally occurring tambjamines 40 
present alkyl substituted imine groups. Nevertheless, during our 
previous studies, we identified the synthetic tambjamine analog 2, 
bearing an aromatic substituent, outperforming the naturally 
occurring derivatives studied.8 Prompted by this result, we 
decided to explore the anion transport and antiproliferative 45 
activities of synthetic tambjamine analogs bearing aromatic 
substituents in the enamine moiety as well as the effect of varying 
the substitution of the alkoxy substituent of the bipyrrole. 
Results and discussion 
Compounds 1-10 were synthesised by acid catalyzed 50 
condensation of the 4-alkoxy-2,2´-bipyrrole aldehyde and the 
corresponding amine (Fig. 1).9 The products were obtained in 
good yields as orange-yellow solids in the form of hydrochloric 
salts. In their protonated form, these compounds are stable for 
several weeks in organic solutions. We decided to explore 55 
aromatic enamine groups bearing both electron donating and 
electron withdrawing substituents as well as a heteroaromatic 
(pyridine) group. We also decided to modify the substitution of 
the pyrrole ring replacing the methoxy group characteristic of the 
naturally occurring derivatives by a benzyloxy group. 60 
Compounds 1 and 2 were previously reported by us.8 
 
Fig. 1 Synthetic tambjamine analogs 1-10. 
 The 1H NMR spectra of these compounds provide evidence of 
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a strong interaction of the chloride anion with the tambjamine 
derivative through the hydrogen cleft formed by the bypyrrole-
enamine moiety. Chloride binding in solution was studied by 1H 
NMR titration experiments of perchlorate salts of compounds 1-
10 with tetrabutylammonium chloride (TBACl) in DMSO-5 
d6/0.5% water. Perchlorate salts of 1-10 were prepared by 
washing crude reaction mixtures with diluted aqueous perchloric 
acid. Addition of TBACl resulted in the effective replacement of 
the perchlorate anion by chloride, as evidenced by the 1H NMR 
spectra indistinguible from that of the corresponding hydrochloric 10 
salt. Fitting of the data obtained in the 1H NMR titration 
experiments using WinEQNMR2 software provided a 
quantitative assessment of the chloride binding affinity for 1-10 
under these conditions (Table 1).10 The values of the association 
constants were found to be similar for all the compounds. Thus 15 
the electronic character of the aromatic substituent as well as the 
nature of the alkoxy substitution of the central pyrrole ring had 
little influence in the calculated Ka value. Although the electronic 
nature of the aromatic substituent should influence the binding 
capability of the molecule, it should be noted that the binding 20 
process involved both the dissociation of the perchlorate anion 
and the coordination of chloride. Thus, since perchlorate is also 
bound by these compounds this effect was not reflected in the 
values of the calculated association constants. 
Table 1: Association constants (Ka, M
-1) of compounds 1-10 with chloride 25 
(added as tetrabutylammonium salt) determined from 1H NMR titration 
experiments in DMSO-d6/0.5 H2O at 293 K. 
Compound Ka (M
-1) Compound Ka (M
-1) 
1 1592 ± 25 6 1428± 30 
2 1990 ± 122 7 1498 ± 48 
3 1789 ± 222 8 1491 ± 59 
4 1681 ± 107 9 1836 ± 114 
5 1510 ± 157 10 1960 ± 219 
 Interestingly, the chemical shift of the NH1' proton (see ESI for 
two-dimensional NMR data) remained almost unaltered during 
the titration experiments with tetrabutylammonium chloride 30 
whereas that of the C-H group in the 3' position experienced an 
important downfield shift (Fig. 2). This result is in agreement 
with the involvement of the C-H3' proton in the binding of 
chloride. Gale and colleagues have described a similar anion 
binding behaviour for a pyrrole group.11 35 
 
Fig. 2 Stack plot of partial 1H NMR of compound 4 in DMSO-d6/0.5 H2O 
solution with the addition of increasing amounts of tetrabutylammonium 
chloride. 
Anion transport assays 40 
The transmembrane anion transport activity of compounds 1-10 
was explored in 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) liposomes. Using a chloride selective 
electrode, the chloride efflux from chloride loaded vesicles was 
monitored over time, according to reported methods.12 The EC50, 45 
defined as the concentration of carrier needed to induce a 50% 
chloride release in the time scale of our experiments (300 
seconds), was calculated using hill plot analyses (Table 2). All 
the compounds proved to be very efficient anion transporters with 
EC50 values in the submicromolar range and down to nanomolar 50 
levels for the most efficient derivatives in the chloride/nitrate 
exchange assay.  
Table 2: Transport activities expressed as EC50 (nM) of compounds 1-10 
Compound 
EC50 (nM) 
NO3ˉ/Clˉ
a 
Hill parameter n 
NO3ˉ/Clˉ 
EC50 (nM) 
HCO3ˉ/Clˉ
b  
Hill parameter n 
HCO3ˉ/Clˉ 
1 40 ± 2 1.17 ± 0.09 460 ± 70 0.89 ± 0.1 
2 50 ± 8 1.14 ± 0.3 240 ± 40 1.19 ± 0.2 
3 140 ± 6 1.18 ± 0.07 890 ± 80 1.04 ± 0.09 
4 70 ± 5 1.39 ±0.2 460 ± 60 0.90 ± 0.1 
5 20 ± 9 0.92 ± 0.3 260 ± 30 1.05 ± 0.08 
6 80 ± 10 1.32 ± 0.3 370 ± 50 1.12 ± 0.2 
7 60 ± 3 1.20 ± 0.09 880 ± 300 0.67 ± 0.1 
8 720 ± 70 1.04 ± 0.09 11920 ± 1000 1.11 ± 0.1 
9 70 ± 3 1.45 ± 0.1 430 ± 100 0.99 ± 0.1 
10 40 ± 2 1.24 ± 0.1 170 ± 20 1.10 ± 0.1 
avesicles loaded with 488 mM NaCl dispersed in 488 mM NaNO3 (5 mM 
phosphate buffer, pH 7.2). bvesicles loaded with 451 mM NaCl dispersed 55 
in 150 mM Na2SO4 (20 mM phosphate buffer, pH 7.2) upon addition of a 
NaHCO3 pulse to make the extravesicular bicarbonate concentration 40 
mM. 
 The transport activity was found to be dependent of the nature 
of the extravesicular anion. Thus, the EC50 values were found to 60 
be roughly an order of magnitude lower when nitrate was used as 
external anion instead of bicarbonate. This result reflected the 
higher lipophilicity of nitrate compared to bicarbonate. The lack 
of significant chloride efflux when sulfate was the only 
extravesicular anion further supported anion exchange as the 65 
transport mechanism accounting for the activity of these 
compounds (Fig. 3). A Hill parameter value around 1 was 
consistent with a non cooperative effect and a carrier mechanism 
for the transmembrane transport activity of these compounds 
(Table 2).  70 
 Similarly to the results observed in the quantification of the 
chloride binding affinity, the nature of the aromatic substituent 
showed little effect in the ionophoric efficiency of these 
compounds. Compounds bearing both electron withdrawing and 
electron donor substituents promoted anion transport with 75 
excellent activity. The trifluoromethyl substituted compounds 3 
and 8 were found to be the less active derivatives, with 8 
displaying the highest EC50 values. When performing transport 
experiments using this compound precipitation of the added 
carrier was evident. It could be possible that the comparatively 80 
lower efficiency of 8 was due to the failure to partition into the 
liposome membranes. Compound 5 was found to be the most 
efficient chloride/nitrate exchanger with a calculated EC50 of 20 
nM. This derivative outperforms our previously reported carrier 2 
(see fig. S106). 85 
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 The replacement of the methoxy group of the central pyrrole 
ring, found in all the naturally occurring derivatives, by a 
benzyloxy group did not result in an important modification of 
the transport efficiency of these derivatives. For this set of 
compounds, comparable results for the parent -OMe and -OBn 5 
derivatives were observed. This was an unexpected result. We 
anticipated that this change would affect to the overall 
lipophilicity of the molecule, a parameter that has been shown by 
us and others to profoundly influence the activity of 
transmembrane anion transporters.13 It could be that in this case 10 
the lipophilicity range of these molecules is adequate to achieve 
an important activity as carriers and the modifications introduced 
in the central pyrrole ring did not result in lipophilicity values 
outside this adequate range. 
 15 
Fig. 3 Comparative of chloride efflux induced by compound 4 (0.5 µM, 
0.1% mol) from: a) POPC liposomes loaded with NaCl (488 mM NaCl 
and 5 mM phosphate buffer, pH 7.2) immersed in NaNO3 (494 mM 
NaNO3 and 5 mM phosphate buffer, pH 7.2); b) vesicles containing NaCl 
(451 mM NaCl and 20 mM phosphate buffer, pH 7.2) immersed in 20 
Na2SO4 (150 mM, Na2SO4; 40 mM HCO3
-
 and 20 mM phosphate buffer, 
pH 7.2); c) vesicles loaded with NaCl (451 mM NaCl and 20 mM 
phosphate buffer, pH 7.2) immersed in Na2SO4 (150 mM, Na2SO4; 20 mM 
phosphate buffer, pH 7.2); d) control experiment (10µL DMSO): vesicles 
loaded with NaCl (451 mM NaCl and 20 mM phosphate buffer, pH 7.2) 25 
immersed in Na2SO4 (150 mM, Na2SO4; 20 mM phosphate buffer, pH 
7.2). All traces are an average of at least three independent experiments. 
Biological studies 
We decided to study the in vitro antitumor activity of compounds 
1-10. A single point screening (10 µM) on a panel of different 30 
cancer cell lines (Human melanoma (A375), human lung 
carcinoma (A549), human colorectal adenocarcinoma (SW620), 
human mammary adenocarcinoma (MDA-MB-231)) using the 
MTT assay revealed the important cytotoxicity of these 
derivatives (Fig. 4).  35 
 
Fig. 4 Single point screening of synthetic tambjamine analogs 1-10 (10 
µM) on a panel of cancer cell lines (A375, A549, SW620, MDA-MB-
231). Cell viability measured using the MTT assay after 48 h treatment. 
 The concentration that causes 50% growth inhibition (IC50 40 
values) was determined for 1-10 on melanoma (A375) and 
mammary adenocarcinoma (MDA-MB-231) human cancer cell 
lines as well as human mammary epithelial (MCF-10A) cell lines 
(Table 3). Compounds 2 and 7 were found to be the most 
cytotoxic compounds in these assays, with IC50 values ranging 45 
from 1.10 to 2.49 µM. On the other hand compound 5 displayed 
significantly higher IC50 values, around 18 µM. Replacement of 
the O-Me group by an O-Bn substituent resulted in an 
enhancement of the cytotoxicity of these compounds with 
average IC50 values of 8.90 µM for the –OMe substituted 1-5 and 50 
and 4.71 µM for the –OBn substituted 6-10 respectively for the 
cancer lines examined. This effect was specially marked for the 
pyridine substituted pair 5 and 10. Little discrimination between 
normal and cancerous cell lines was observed and significant 
toxicity against the non cancerous human mammary epithelial 55 
cell line MCF-10A line was detected. Average IC50 values on this 
cell line for compounds 1-5 was 12.70 µM and 10.56 µM for 
compounds 6-10 respectively. 
 Table 3: IC50 of compounds 1-10 on human melanoma (A375), human 
mammary adenocarcinoma (MDA-MB-231) and human mammary 60 
epithelial (MCF-10A) cell lines. 
Compound 
IC50 (µM)  
A375 
IC50 (µM)  
MDA-MB-231 
IC50 (µM)  
MCF-10A 
1 8.19 ± 2.90 6.58 ± 1.01 10.90± 4.34 
2 1.10 ± 0.01 2.28 ± 0.56 2.36 ± 0.01 
3 5.20 ± 0.08 8.13 ± 1.56 4.12 ± 1.13 
4 8.30 ± 2.44 13.67± 4.31 26.27± 8.76 
5 17.48± 1.94 18.11± 1.16 19.86± 1.79 
6 1.56 ± 0.69 4.71 ± 2.87 4.90 ± 1.53 
7 1.18 ± 0.04 2.49 ± 0.65 2.80 ± 0.72 
8 1.29 ± 0.11 3.85 ± 1.39 3.90 ± 1.28 
9 6.75 ± 2.85 19.11± 0.67 36.50± 4.72 
10 2.74 ± 0.53 3.43 ± 1.68 4.70 ± 1.79 
 
In order to analyze the cell death induced by these 
compounds we used Hoechst 33342 staining (Fig. 5). This DNA 
binding dye allows the differentiation of apoptosis from other cell 65 
death mechanisms. In contrast to untreated cells (control), cells 
treated with compounds 1-10 showed stronger blue fluorescence 
indicating chromatin condensation, fragmentation and apoptotic 
bodies formation, along with “bean” shaped nuclei. All these 
features are hallmarks of apoptosis. 70 
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Fig. 5 Hoechst 33342 staining on melanoma (A375) human cancer cell 
line. a) Untreated (control) cells; b)-k) cells treated with compounds 1-10. 
Treated cells showed typical features of apoptotic processes. 
Finally, vital staining with acridine orange (AO) was used to 5 
evaluate the effects of these compounds on the intracellular pH 
levels. Protonation and accumulation of this dye in acidic 
compartments such as lysosomes results in a characteristic orange 
fluorescence emission, whereas it emits green fluorescence at 
higher pH.14 Human melanoma (A375) cells were stained with 10 
AO and granular orange fluorescence was observed in the 
cytoplasm, corresponding to acidic organelles (Fig. 6). Treatment 
of these cells with compounds 1-10 resulted in the disappearance 
of the orange fluorescence, suggesting the basification of acidic 
organelles. The observed qualitative results correlate well with 15 
the antiproliferative activity of these derivatives. The effect was 
more evident for the most cytotoxic compounds whereas the 
action of the less toxic derivatives such as 5 led only to minimal 
changes and appearance similar to untreated cells. 
 20 
 
Fig. 6 Acridine orange staining on melanoma (A375) human cancer cell 
line. a) Untreated (control) cells; b)-k) cells treated with compounds 1-10. 
Treated cells showed significant disappearance of orange fluorescence 
due to basification of acidic organelles. 25 
Conclusions  
Synthetic analogs of tambjamine alkaloids bearing aromatic 
enamine substituents represent privileged structures for the 
development of highly efficient transmembrane anion 
transporters. These compounds efficiently promoted nitrate and 30 
bicarbonate/chloride exchange in model liposomes at very low 
concentrations. At this stage it is unclear which parameters make 
these compounds so effective as anionophores and studies aimed 
to shed light on this matter are currently underway in our 
laboratories. In vitro studies showed that they were able to alter 35 
the intracellular pH levels, triggering apoptosis in different cancer 
cell lines with IC50 values in the low micromolar range. The 
toxicity of these compounds is an important issue to be addressed 
in order to continue their development as potential anticancer 
drugs. The tolerance of this motif regarding changes in both the 40 
electronic nature of the aromatic enamine substituent as well as 
the alkoxy group of central pyrrole ring suggest that it could be 
possible to introduce modifications aimed to increase the 
selectivity toward cancer cells without losing their anionophoric 
properties. 45 
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Experimental section 
General Procedures and Methods  
Commercial reagents were used as received without any further 
purification. NMR spectra were recorded in Varian Mercury-300 
MHz and Varian Unity Inova-400 MHz spectrometers. Chemical 5 
shifts are reported in ppm with using residual solvent peak as 
reference, coupling constants are reported in Hz. High resolution 
mass spectra (HRMS) were recorded on a MicromassAutospec S-
2 spectrometer using EI at 70eV. 4-Methoxy-2,2'-bipyrrole-5-
carboxaldehyde and 4-Benzyloxy-2,2'-bipyrrole-5-10 
carboxaldehyde were prepared as described.15 1H NMR titrations 
experiments were performed in DMSO-d6/H2O 99.5:0.5 mixtures 
at 303 K. Data fitting was carried out using WinEQNMR2 
software (see the Supporting Information for details).9 
 15 
Synthesis of tambjamine analogs  
Compounds 1-10 were synthesised using modifications of the 
previously reported method.9 To a mixture of the 2,2'-bipyrrole-5-
carboxaldehyde (190 mg, 1 mmol,) and the corresponding amine 
(1.3-3 mmol, 1.3-3 equivalents) in 10 mL of chloroform, 40 µL 20 
of acetic acid were added. The mixture was stirred at 60 ºC until 
TLC showed disappearance of the starting material. The reaction 
was then diluted with 40 mL of dichloromethane and washed 
with HCl 1M (3 x 25 mL). The organic fraction was dried over 
Na2SO4 and the solvent evaporated to yield 1-10 as yellow-25 
orange solids in good to excellent yields. 
 (Z)-1-(4-methoxy-1H,1'H-[2,2'-bipyrrol]-5-yl)-N-
phenylmethanimine (1). Yield 94 %. 1H NMR (300 MHz, 
DMSO-d6): δ 13.61 (s. NH, 1H), 11.07 (d, NH, 1H, J = 14.3 Hz), 
10.63 (s, NH, 1H), 7.61 (d, 1H, J = 14.1 Hz), 7.28 (t, 4H, J = 5.2 30 
Hz), 7.13 – 7.05 (m, 1H), 7.01 (d, 1H, J = 1.1 Hz), 6.76 (s, 1H), 
6.21 (m, 1H), 5.95 (s, 1H), 3.86 (s, 3H);13C NMR (75 MHz, 
CDCl3):δ 165.47 (C), 144.58 (C), 138.60 (C), 130.02 (CH), 
129.96 (CH), 125.88 (CH), 125.34 (CH), 122.65 (C), 117.17 
(CH), 115.17 (CH), 113.60 (C), 111.57 (CH), 92.40 (CH), 59.03 35 
(CH3); HRMS (EI) m/z calcd for [C16H15N3O] 265.1215; 
found: 265.1208. 
 (Z)-N-(4-(tert-butyl)phenyl)-1-(4-methoxy-1H,1'H-[2,2'-
bipyrrol]-5-yl)methanimine (2). Yield 95 %. 1H NMR (300 
MHz, CDCl3): δ = 13.94 (s, NH, 1H), 11.22 (d, NH, J = 14.4 Hz, 40 
1H), 10.70 (s, NH, 1H), 7.77 (d, NH, J = 14.6 Hz, 1H), 7.40 (d, J 
= 8.6 Hz, 2H), 7.32 (d, J = 8.4 Hz, 2H), 7.25 (s, 1H), 7.13 (s, 1H), 
6.81 (s, 1H), 6.32 (d, J = 1.5 Hz, 1H), 6.00 (s, 1H), 3.98 (s, 3H), 
1.31 (s, 9H); 13C NMR (75 MHz, CDCl3): δ = 165.01 (C), 149.16 
(C), 143.95 (C), 135.97 (C), 130.15 (CH), 126.71 (CH), 124.99 45 
(CH), 122.53 (C), 116.88 (CH), 114.67 (CH), 113.17 (C), 111.27 
(CH), 92.06 (CH), 58.79 (CH3), 34.58 (C), 31.31 (CH3); HRMS 
(EI) m/z calcd for [C20H23N3O] 321.1841; found: 321.1844. 
 (Z)-1-(4-methoxy-1H,1'H-[2,2'-bipyrrol]-5-yl)-N-(4-
(trifluoromethyl)phenyl)methanimine (3). Yield 80 %. 1H 50 
NMR (300 MHz, DMSO-d6): δ = 13.29 (s, NH, 1H), 12.58 (d, 
NH, J = 13.9 Hz, 1H), 12.13 (s, NH, 1H), 8.31 (d, J = 13.7 Hz, 
1H), 7.77 (s, 4H), 7.29 (s, 2H), 6.61 (s, 1H), 6.36 (s, 1H), 4.01 (s, 
3H). 13C NMR (75 MHz, DMSO): δ = 166.37 (C), 145.47 (C), 
142.22 (C), 131.32 (CH), 127.00 (c, JC-F = 3.7 Hz CH), 126.12 55 
(CH), 124.99 (c, JC-F = 32.2 Hz, C) 124.22 (c, JC-F = 271.1 Hz, 
CF3) 121.95 (C), 117.53 (CH), 114.00 (CH), 113.90 (C), 111.57 
(CH), 92.98 (CH), 59.13 (CH3). HRMS (EI) m/z calcd for 
[C17H14F3N3O] 333.1089; found: 333.1088. 
 (Z)-1-(4-methoxy-1H,1'H-[2,2'-bipyrrol]-5-yl)-N-(4-60 
methoxyphenyl)methanimine (4). Yield 92 %. 1H NMR (300 
MHz, CDCl3): δ = 13.65 (s, 1H), 11.17 (d, J = 13.7 Hz, 1H), 
10.58 (s, 1H), 7.64 (d, J = 13.8 Hz, 1H), 7.36 – 7.22 (m, 2H), 
7.07 (s, 1H), 6.93 – 6.81 (m, 2H), 6.76 (d, J = 1.3 Hz, 1H), 6.26 
(d, J = 1.7 Hz, 1H), 5.94 (s, 1H), 3.91 (s, 3H), 3.77 (s, 3H). 13C 65 
NMR (75 MHz, CDCl3) δ = 164.71 (C), 157.83 (C), 143.42 (C), 
131.86 (C), 130.43 (CH), 124.88 (CH), 122.65 (C), 118.59 (CH), 
115.05 (CH), 114.35 (CH), 112.89 (C), 111.24 (CH), 91.91 (CH), 
58.76 (CH3), 55.65 (CH3). HRMS (EI) m/z calcd for 
[C17H17N3O2] 295.1321; found: 295.1322. 70 
 (Z)-1-(4-methoxy-1H,1'H-[2,2'-bipyrrol]-5-yl)-N-(pyridin-
2-yl)methanimine (5). Yield 65 %. 1H NMR (300 MHz, CDCl3): 
δ = 13.85 (s, NH, 1H), 11.41 (d, J = 13.1 Hz, NH, 1H), 10.73 (s, 
NH, 1H), 8.63 (d, J = 13.4 Hz, 1H), 8.33 (d, J = 4.0 Hz, 1H), 7.69 
(s, 1H), 7.35 (d, J = 8.1 Hz, 1H), 7.16 (s, 1H), 7.08 (dd, J = 7.3, 75 
5.0 Hz, 1H), 6.88 (s, 1H), 6.34 (s, 1H), 6.02 (d, J = 1.8 Hz, 1H), 
4.00 (s, 3H). 13C NMR (75 MHz, CDCl3): δ = 166.68 (C), 150.02 
(C), 148.49 (CH), 145.97 (C), 138.92 (CH), 128.83 (CH), 126.23 
(CH), 122.40 (C), 120.69 (CH), 116.04 (CH), 114.73 (C), 113.85 
(CH), 111.79 (CH), 92.47 (CH), 58.98 (CH3). HRMS (EI) m/z 80 
calcd for [C15H14N4O] 266.1168; found: 266.1168. 
 (Z)-1-(4-(benzyloxy)-1H,1'H-[2,2'-bipyrrol]-5-yl)-N-
phenylmethanimine (6). Yield 94 %. 1H NMR (300 MHz, 
CDCl3): δ = 14.03 (s, NH, 1H), 11.28 (d, NH, J = 14.5 Hz, 1H), 
10.73 (s, NH, 1H), 7.83 (d, J = 14.6 Hz, 1H), 7.45 (d, J = 1.4 Hz, 85 
4H), 7.41 – 7.38 (m, 3H), 7.26 (dd, J = 1.5, 0.6 Hz, 2H), 7.20 (s, 
1H), 7.15 (s, 1H), 6.83 (s, 1H), 6.33 (dt, J = 3.5, 2.1 Hz, 1H), 6.06 
(s, 1H), 5.20 (s, 2H). 13C NMR (75 MHz, CDCl3): δ = 164.17 (C), 
144.49 (C), 138.52 (C), 134.79 (C), 130.21 (CH), 129.94 (CH), 
129.07 (CH), 128.97 (CH), 128.26 (CH), 125.93 (CH), 125.46 90 
(CH), 122.55 (C), 117.27 (CH), 115.11 (CH), 113.81 (C), 111.45 
(CH), 93.13 (CH), 73.88 (CH2). HRMS (EI) m/z calcd for 
[C22H19N3O] 341.1528; found: 341.1515. 
 (Z)-N-((4-(benzyloxy)-1H,1'H-[2,2'-bipyrrol]-5-
yl)methylene)-4-(tert-butyl)aniline (7). Yield 92 %. 1H NMR 95 
(300 MHz, CDCl3): δ = 13.83 (s, NH, 1H), 11.23 (d, NH, J = 14.5 
Hz, 1H), 10.69 (s, NH, 1H), 7.73 (d, J = 14.4 Hz, 1H), 7.61 – 
7.13 (m, 9H), 7.05 (s, 1H), 6.78 (s, 1H), 6.27 (s, 1H), 6.07 (s, 
1H), 5.18 (s, 2H), 1.29 (s, 9H). 13C NMR (75 MHz, CDCl3): δ = 
163.86 (C), 149.36 (C), 143.97 (C), 136.01 (C), 134.84 (C), 100 
130.53 (CH), 129.03 (CH), 128.95 (CH), 128.22 (CH), 126.79 
(CH), 125.22 (CH), 122.59 (C), 117.10 (CH), 114.75 (CH), 
113.49 (C), 111.32 (CH), 93.00 (CH), 73.77 (CH2), 34.66 (C), 
31.36 (CH3). HRMS (EI) m/z calcd for [C26H27N3O] 397.2154; 
found: 397.2165. 105 
 (Z)-1-(4-(benzyloxy)-1H,1'H-[2,2'-bipyrrol]-5-yl)-N-(4-
(trifluoromethyl)phenyl)methanimine (8). Yield 44 %. 1H 
NMR (300 MHz, CDCl3): δ = 14.03 (s, NH, 1H), 11.32 (d, NH, J 
= 13.3 Hz, 1H), 10.73 (s, NH, 1H), 7.78 (d, J = 14.1 Hz, 1H), 
7.60 (d, J = 8.4 Hz, 2H), 7.17 (s, 1H), 6.88 (s, 1H), 6.35 (s, 1H), 110 
6.07 (s, 1H), 5.20 (s, 2H). 13C NMR (75 MHz, CDCl3): δ = 
164.93 (C), 146.14 (C), 141.55 (C), 134.49 (CH), 129.33 (CH), 
129.12 (CH), 128.90 (C), 128.35 (CH), 127.38 (c, JC-F= 33.68 Hz, 
C), 127.25 (c, JC-F= 3.7 Hz, CH), 126.63 (CH), 123.96 (c, JC-F= 
271.8 Hz, CF3), 122.36 (C), 117.04 (CH), 116.41 (CH), 115.05 115 
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(C), 111.98 (CH), 93.50 (CH), 74.19 (CH2). HRMS (EI) m/z 
calcd for [C23H18F3N3O] 409.1402; found: 409.1402. 
 (Z)-1-(4-(benzyloxy)-1H,1'H-[2,2'-bipyrrol]-5-yl)-N-(4-
methoxyphenyl)methanimine (9). Yield 97 %. 1H NMR (300 
MHz, DMSO): δ = 13.12 (s, 1H), 12.58 (d, J = 14.5 Hz, 1H), 5 
11.96 (s, 1H), 8.23 (d, J = 14.4 Hz, 1H), 7.69 – 7.50 (m, 4H), 
7.40 (ddd, J = 8.5, 7.7, 3.6 Hz, 3H), 7.24 – 7.12 (m, 2H), 7.00 (d, 
J = 9.0 Hz, 2H), 6.61 (d, J = 1.9 Hz, 1H), 6.30 (d, J = 2.2 Hz, 
1H), 5.30 (s, 2H), 3.75 (s, 3H). 13C NMR (75 MHz, DMSO): δ = 
163.40 (C), 157.45 (C), 142.47 (C), 135.53 (C), 132.88 (CH), 10 
131.85 (C), 128.55 (CH), 128.37 (CH), 127.95 (CH), 124.56 
(CH), 122.16 (C), 119.12 (CH), 114.93 (CH), 112.49 (C), 112.24 
(CH), 110.89 (CH), 93.25 (CH), 72.82 (CH2), 55.47 (CH3). 
HRMS (EI) m/z calcd for [C23H21N3O2] 371.1634; found: 
371.1635. 15 
 (Z)-1-(4-(benzyloxy)-1H,1'H-[2,2'-bipyrrol]-5-yl)-N-
(pyridin-2-yl)methanimine (10). Yield 46 %. 1H NMR (300 
MHz, DMSO):δ= 13.21 (s, 1H), 12.82 (s, 1H), 12.20 (s, 1H), 8.50 
(s, 1H), 8.38 (dd, J = 4.9, 1.5 Hz, 1H), 7.87 (td, J = 7.7, 1.6 Hz, 
1H), 7.55 (dd, J = 7.9, 1.6 Hz, 2H), 7.43 (dd, J = 11.1, 3.8 Hz, 20 
3H), 7.34 – 7.15 (m, 4H), 6.70 (s, 1H), 6.37 (s, 1H), 5.32 (s, 2H). 
13C NMR (75 MHz, DMSO):δ= 165.39 (C), 149.82 (C), 148.80 
(CH), 145.75 (C), 139.48 (CH), 135.13 (C), 128.71 (CH), 128.49 
(CH), 127.75 (CH), 126.28 (CH), 121.86 (C), 120.98 (CH), 
114.11 (CH), 113.98 (C), 112.92 (CH), 111.64 (CH), 93.89 (CH), 25 
73.38 (CH2). HRMS (EI) m/z calcd for [C21H18N4O] 342.1481; 
found: 342.1490. 
Preparation of Phospholipid Vesicles 
A chloroform solution of 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC) (20 mg/mL) (Sigma-Aldrich) was 30 
evaporated in vacuo using a rotary evaporator and the lipid film 
obtained was dried under high vacuum for at least 2 hours. The 
lipid film was rehydrated by addition of a sodium chloride 
solution (488 mM NaCl and 5 mM phosphate buffer, pH 7.2 or 
451 mM NaCl and 20 mM phosphate buffer, pH 7.2) and 35 
followed by careful vortexing. The lipid suspension was then 
subjected to nine freeze-thaw cycles and twenty-nine extrusions 
through a 200 nm polycarbonate Nucleopore membrane using a 
LiposoFast Basic extruder (Avestin, Inc.). The resulting 
unilamellar vesicles were dialyzed against NaNO3 solution (488 40 
mM NaNO3 and 5 mM phosphate buffer, pH 7.2) or a Na2SO4 
solution (150 mM Na2SO4 and 20 mM phosphate buffer, pH 7.2) 
to remove unencapsulated chloride. 
ISE Transport Assays 
Unilamellar vesicles (200 nm mean diameter) composed of POPC 45 
containing an encapsulated solution of 488 mM NaCl and 5 mM 
phosphate buffer, pH 7.2 or 451 mM NaCl and 20 mM phosphate 
buffer, pH 7.2, were suspended in a solution 494 mM NaNO3 and 
5 mM phosphate buffer, pH 7.2 or 150 mM Na2SO4 and 20 mM 
phosphate buffer, pH 7.2 respectively, for a final lipid 50 
concentration of 0.5 mM and a total volume of 5 mL. A DMSO 
solution of the carrier molecule, typically 5 μL to avoid influence 
of the solvent molecules in the assay, was added and the chloride 
release from vesicles was monitored using a sympHony 
combination chloride electrode. At the end of the experiment the 55 
vesicles were lysed with detergent (triton-X 10% dispersion in 
water, 20 μL) to release all chloride ions; the resulting value was 
considered to represent 100% release and used as such. For the 
bicarbonate anion exchange assays to the vesicles suspended in a 
Na2SO4 solution of NaHCO3 (150 mM in Na2SO4 buffered to pH 60 
7.2 with 20 mM sodium phosphate salts) was added for a final 
concentration of 40 mM and the chloride efflux was monitored 
for another 5 minutes before they were lysed with detergent to 
release all chloride ions; the resulting value was considered to 
represent 100% release and used as such. For the experiments 65 
using NaNO3 as external solution vesicles containing an 
encapsulated solution of 488 mM NaCl and 5 mM phosphate 
buffer, were suspended in a 494 mM NaNO3 and 5 mM 
phosphate buffer, pH 7.2 solution. 
Cell lines and Culture Conditions 70 
Human melanoma (A375), human lung carcinoma (A549), 
human colorectal adenocarcinoma (SW620), human mammary 
adenocarcinoma (MDA-MB-231) and human mammary 
epithelial (MCF-10A) cell lines were purchased from the 
American Type Culture Collection (ATCC, Manassas, VA). Cells 75 
were cultured in DMEM medium (Biological Industries) 
supplemented with 10% heat-inactivated foetal bovine serum 
(FBS; Life Technologies, Carlsbad, CA), 100 U/ml penicillin, 
100 µg/ml streptomycin, and 2 mM L- glutamine, all from 
Biological Industries. MDA-MB-231 cell line was cultured in 80 
DMEM:F12 media (1:1, Biological Industries) supplemented 
with 10% heat-inactivated FBS), 100 U/ml penicillin, 100 µg/ml 
streptomycin, and 2 mM L- glutamine. MCF10A cell line was 
cultured in DMEM:F12 media (1:1) supplemented with 5% horse 
serum (Life Technologies), 20 ng/ml EGF, 0.5 µg/ml 85 
Hydrocortisone, 100 ng/ml Cholera toxin, 10 µg/ml insulin all 
from Sigma-Aldrich Chemical Co. (St. Louis, MO) and 100 U/ml 
penicillin, 100 µg/ml streptomycin, and 2 mM L- glutamine. 
Cells were grown at 37ºC in a 5% CO2 atmosphere. 
Cell Viability Assay 90 
Cells (1 x 105 cells/ ml) were seeded in 96-well plates and 
allowed to grow for 24 h. Afterwards, they were treated with 10 
µM of each compound for single point experiments and dose 
response curves were performed ranging from 0.39 to 50 µM for 
48 h to calculate the inhibitory concentration of 50% of cell 95 
population (IC50) values of the most potent compounds. Cell 
viability was determined by MTT assay. After treatment, 10 µM 
of 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(Sigma-Aldrich) was added to each well for an additional 4 h. 
DMSO was added in control cells. Media was aspirated and the 100 
blue MTT formazan precipitate was dissolved in 100 µl of 
DMSO. The absorbance at 570 nm was measured on a multiwell 
plate reader. Cell viability was expressed as a percentage of 
control cells, and data are shown as the mean value ± S.D. of 
three independent experiments performed in triplicate for single 105 
point evaluation or in duplicate for dose-response curves. IC50 
values were calculated with GraphPad Prism 5 software. 
Acridine Orange Staining  
A375 cells (105 cells/ ml) were seeded on glass slices and 48 h 
later they were treated with IC50 value during 1:30 h. DMSO was 110 
added in control cells. Afterwards, cells were washed twice with 
PBS and incubated in 5 µg/ml acridine orange solution during 30 
min at room temperature. Finally, they were washed with PBS-
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10% FBS three times and examined by fluorescence in a NIKON 
eclipse E800 microscope (SCT filter 330/380nm). 
Hoechst Staining 
A375 cells (105 cells/ ml) were seeded in 12-well plates, allowed 
to grow for 24 h and then treated with 10 μM of each compound 5 
for 48 h. DMSO was added in control cells. They were washed in 
PBS, resuspended in 2 µg/ml Hoechst 33342 (Sigma-Aldrich 
Chemical Co.) and incubated for 30 min at 37ºC in the dark. 
Finally, cells were washed in PBS and examined by fluorescence 
in a NIKON eclipse E800 microscope (SCT filter 330/380nm). 10 
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